
From Intelligence to Intervention:
Shaping the Future of Neurovascular Care
The ARISE IV Consensus Conference, taking place May 21–22, 2026, in Washington, DC, will bring together the three essential stakeholders in neurovascular research and care: academia, industry, and regulatory agencies. With a broadened identity that includes artificial intelligence, robotics, arterial and venous disease, and cerebrospinal fluid (CSF) spaces, ARISE IV is focused on shaping the future of neurointerventional care.
The mission of ARISE IV is to:
The meeting will feature three core scientific sessions on Thursday, followed by a combined AI and Robotics workshop on Friday, with confirmed FDA participation focused on clinical trial design and device classification. Through initiatives such as the launch of the AI Vessel Sizing Consensus Initiative, ARISE IV aims to deliver practical guidance and foster alignment across the neurointerventional ecosystem.
WHY ATTEND
The neurointerventional landscape is evolving faster than ever. AI-powered imaging, remote robotics, and ambulatory care models are no longer future concepts—they’re reshaping practice today. ARISEIV is where thought leaders, innovators, and regulators converge to define what comes next.
What to Expect:
✓ Consensus-building workshops on emerging standards
✓ Deep dives into AI integration and remote intervention
✓ NEW: Ambulatory Neuro Interventional Centers session
✓ Active FDA and NIH participation on regulatory pathways
✓ Industry participation in consensus statement preparation
✓ Intimate format fostering meaningful collaboration
LEARN MORE



